HUMA
USDHumacyte Inc. Common Stock
$1.330+0.030 (2.308%)
실시간 가격
Healthcare
생명공학
미국
가격 차트
Loading Chart...
핵심 지표
시장 지표
시가
$1.300
고가
$1.340
저가
$1.220
거래량
3.25M
기업 기본 정보
시가총액
249.1M
산업
생명공학
국가
United States
거래 통계
평균 거래량
5.40M
거래소
NMS
통화
USD
52주 범위
저가 $1.15현재가 $1.330고가 $6.77
관련 뉴스
Analyst Upgrades
BTIG Maintains Buy on Humacyte, Lowers Price Target to $6
BTIG analyst Ryan Zimmerman maintains Humacyte with a Buy and lowers the price target from $7 to $6.
더 보기
GlobeNewswire
Humacyte Announces Pricing of $60.0 Million Oversubscribed Registered Direct Offering
DURHAM, N.C., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today
더 보기
Analyst Upgrades
D. Boral Capital Maintains Buy on Humacyte, Maintains $25 Price Target
D. Boral Capital analyst Jason Kolbert maintains Humacyte with a Buy and maintains $25 price target.
더 보기
GlobeNewswire
Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus
– Patent covers esophagus produced using Humacyte's proprietary bioengineered regenerative tissue platform, designed for implant in patients with damaged esophagus –
더 보기
